|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.53 BRL | -1.74% |
|
-1.74% | -38.50% |
| 05-07 | Raia Drogasil S.A., Q1 2025 Earnings Call, May 07, 2025 | |
| 05-06 | Brazil's RD posts Q1 adjusted net profit of 177.1 million reais | RE |
| Capitalization | 24B 4.32B 3.71B 3.45B 3.21B 5.93B 372B 6.62B 41.73B 15.75B 174B 16.21B 15.87B 641B | P/E ratio 2025 * |
21.8x | P/E ratio 2026 * | 17.5x |
|---|---|---|---|---|---|
| Enterprise value | 31.39B 5.65B 4.85B 4.52B 4.2B 7.76B 487B 8.66B 54.59B 20.61B 228B 21.2B 20.76B 839B | EV / Sales 2025 * |
0.71x | EV / Sales 2026 * | 0.64x |
| Free-Float |
74.54% | Yield 2025 * |
1.94% | Yield 2026 * | 2.75% |
More valuation ratios
* Estimated data
More news
Last Transcript: Raia Drogasil S.A.
More press releases
| 1 day | -1.74% | ||
| 1 week | -1.74% | ||
| Current month | -10.52% | ||
| 1 month | -5.52% | ||
| 3 months | -32.85% | ||
| 6 months | -36.92% | ||
| Current year | -38.50% |
| 1 week | 13.23 |  | 14.11 |
| 1 month | 13.23 | | 15.96 |
| Current year | 13.23 | | 22.8 |
| 1 year | 13.23 | | 30.4 |
| 3 years | 13.23 | | 30.4 |
| 5 years | 13.23 | | 30.4 |
| 10 years | 6.59 | | 30.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renato Raduan
CEO | Chief Executive Officer | 49 | 2024-12-31 |
| Director of Finance/CFO | 62 | 2013-04-28 | |
| Chief Operating Officer | 49 | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 72 | 2011-11-23 | |
| Director/Board Member | 71 | 2011-11-23 | |
| Director/Board Member | 73 | 2013-04-28 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 2.01% | 0 M€ | -.--% | - | |
| 1.21% | 14 M€ | +11.95% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.74% | -1.74% | -47.27% | -31.66% | 4.31B | ||
| -0.26% | +4.69% | +4.46% | -22.08% | 1.37B | ||
| +1.08% | +7.18% | +119.00% | +142.61% | 654M | ||
| -1.59% | +1.16% | +25.84% | +35.94% | 492M | ||
| -6.90% | +23.88% | +22.54% | +18.46% | 89.92M | ||
| 0.00% | -5.68% | +6.41% | -35.66% | 70.68M | ||
| +6.09% | -0.30% | -10.90% | -84.58% | 64.36M | ||
| Average | -0.47% | +5.05% | +17.15% | +3.29% | 1.01B | |
| Weighted average by Cap. | -1.16% | +2.34% | -14.93% | -8.82% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 44.12B 7.94B 6.82B 6.35B 5.91B 10.9B 684B 12.17B 76.73B 28.96B 321B 29.8B 29.18B 1,179B | 50.3B 9.06B 7.77B 7.24B 6.74B 12.43B 780B 13.88B 87.47B 33.02B 366B 33.97B 33.27B 1,344B |
| Net income | 1.09B 197M 169M 157M 146M 270M 16.93B 301M 1.9B 717M 7.94B 737M 722M 29.18B | 1.38B 248M 213M 198M 185M 341M 21.38B 380M 2.4B 905M 10.02B 931M 912M 36.84B |
| Net Debt | 7.4B 1.33B 1.14B 1.06B 990M 1.83B 115B 2.04B 12.86B 4.85B 53.77B 4.99B 4.89B 198B | 8.15B 1.47B 1.26B 1.17B 1.09B 2.01B 126B 2.25B 14.17B 5.35B 59.24B 5.5B 5.39B 218B |
More financial data
* Estimated data
Employees
66,275
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-07-18 | 13.53 R$ | -1.74% | 8,911,800 |
| 25-07-17 | 14.01 R$ | +1.52% | 11,194,800 |
| 25-07-16 | 13.80 R$ | +3.29% | 9,168,800 |
| 25-07-15 | 13.36 R$ | -1.98% | 6,884,200 |
| 25-07-14 | 13.63 R$ | -1.02% | 6,172,300 |
Delayed Quote Sao Paulo, July 18, 2025 at 04:07 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
14.01BRL
Average target price
19.51BRL
Spread / Average Target
+39.23%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RADL3 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition